Neuroscience Graduate Program, Department of Psychiatry and Behavioural Neurosciences, McMaster University, 100 West 5th St., Hamilton, ON, L8N 3K7, Canada.
Health Science Library, McMaster University, 1280 Main St. W., Hamilton, ON, L8S 4L8, Canada.
BMC Med Genomics. 2021 Aug 12;14(1):203. doi: 10.1186/s12920-021-01035-5.
With the increase in cannabis use rates, cannabis use disorder is being reported as one of the most common drug use disorders globally. Cannabis use has several known physical, psychological, and social adverse events, such as altered judgement, poor educational outcomes, and respiratory symptoms. The propensity for taking cannabis and the development of a cannabis use disorder may be genetically influenced for some individuals. Heritability estimates suggest a genetic basis for cannabis use, and several genome-wide association studies (GWASs) have identified possible regions of association, albeit with inconsistent findings. This systematic review aims to summarize the findings from GWASs investigating cannabis use and cannabis use disorder.
This systematic review incorporates articles that have performed a GWAS investigating cannabis use or cannabis use disorder. MEDLINE, Web of Science, EMBASE, CINAHL, GWAS Catalog, GWAS Central, and NIH Database of Genotype and Phenotype were searched using a comprehensive search strategy. All studies were screened in duplicate, and the quality of evidence was assessed using the quality of genetic association studies (Q-Genie) tool. All studies underwent qualitative synthesis; however, quantitative analysis was not feasible.
Our search identified 5984 articles. Six studies met our eligibility criteria and were included in this review. All six studies reported results that met our significance threshold of p ≤ 1.0 × 10. In total 96 genetic variants were identified. While meta-analysis was not possible, this review identified the following genes, ANKFN1, INTS7, PI4K2B, CSMD1, CST7, ACSS1, and SCN9A, to be associated with cannabis use. These regions were previously reported in different mental health conditions, however not in relation to cannabis use.
This systematic review summarized GWAS findings within the field of cannabis research. While a meta-analysis was not possible, the summary of findings serves to inform future candidate gene studies and replication efforts. Systematic Review Registration PROSPERO CRD42020176016.
随着大麻使用率的增加,大麻使用障碍被报告为全球最常见的药物使用障碍之一。大麻使用会导致一些已知的身体、心理和社会不良事件,例如判断力下降、教育成果不佳和呼吸道症状。对于某些个体来说,吸食大麻和发展大麻使用障碍的倾向可能受到遗传影响。遗传力估计表明大麻使用存在遗传基础,并且几项全基因组关联研究(GWAS)已经确定了可能的关联区域,尽管结果不一致。本系统评价旨在总结调查大麻使用和大麻使用障碍的 GWAS 研究结果。
本系统评价纳入了进行 GWAS 调查大麻使用或大麻使用障碍的文章。使用全面的搜索策略在 MEDLINE、Web of Science、EMBASE、CINAHL、GWAS Catalog、GWAS Central 和 NIH 基因型和表型数据库中搜索。所有研究均由两人进行筛选,使用遗传关联研究质量(Q-Genie)工具评估证据质量。所有研究均进行了定性综合分析;但是,无法进行定量分析。
我们的搜索确定了 5984 篇文章。符合纳入标准的研究有 6 项,纳入本综述。这 6 项研究均报告了符合我们显著性阈值 p≤1.0×10 的结果。总共确定了 96 个遗传变异。虽然无法进行荟萃分析,但本综述确定了以下基因与大麻使用相关:ANKFN1、INTS7、PI4K2B、CSMD1、CST7、ACSS1 和 SCN9A。这些区域先前在不同的心理健康状况中报告过,但与大麻使用无关。
本系统评价总结了大麻研究领域的 GWAS 研究结果。虽然无法进行荟萃分析,但研究结果的总结有助于为未来的候选基因研究和复制工作提供信息。系统评价注册 PROSPERO CRD42020176016。